To identify potential therapeutic vulnerabilities in p21 high-expressing cells, we next performed a systematic correlation analysis using 1442 cancer cell lines from the Dependency Map dataset [https://depmap.org/portal/ (accessed on 20 April 2024)], integrating RNA expression with drug sensitivity profiles (area under the curve (AUC) values). Here, CDKN1A is linked to cancer.